Peer Reviewed Mild Cognitive Impairment Journals
Alzheimer’s illness is characterised by the progressive loss of psychological feature functions and memory, however also can be among neurobehavioral manifestations. delicate psychological feature impairment (MCI) is believed to be the intermediate stage between expected psychological feature decline of traditional
aging and therefore the additional pronounced decline seen in insanity. As Per the 2011 updates pointers for AD, the symptomatic predementia section of AD is currently mentioned as MCI because of AD. There are many studies and reviews performed on evaluating the effectiveness of internal secretion in AD patients with
sleep disorders and in patients with delicate psychological feature impairment. A review of internal secretion physiological activities and evidence-based therapeutic interventions in patients with delicate psychological feature impairment and
Alzheimer illness. The goal of peer-review is to assess the standard of
articles submitted for publication in an exceedingly donnish
Open Access Journals. Peer-reviewed
articles offer a trustworthy sort of scientific communication. The referee method is very appreciated by researchers globally .Melatonin medical aid was additionally seen to boost sleep quality, psychological feature performance, memory, and depression in patients with delicate psychological feature impairment. Though melatonin therapy doesn't seem to be a possible cure for
Alzheimer malady it will offer some vital medicine edges within the acceptable patient population.
High Impact List of Articles
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
-
CGRP antagonists for the treatment of migraine: rationale and clinical data
Lars Edvinsson, Mattias Linde
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical